Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Cure51
France
- Paris
- 20/03/2024
- Seed
- $16,260,975
The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer.
- Industry Biotechnology Research
- Website https://www.cure51.com/
- LinkedIn https://www.linkedin.com/company/cure51/
Related People
Nicolas WolikowFounder
France -
Greater Paris Metropolitan Region
Over 20 years operating as a Managing Director and revenue generation, digital business development and strategic leadership experiences within start-up and multinational firms.
Forward-thinking executive with a strong ability to lead and motivate worldwide teams comprising of more than 400 employees.
Managing P&L for business divisions exceeding $200M revenue.
Have been Chief Executive Officer, responsible for strategy implementation, business development and acquisitions initiatives. Currently Chief Digital Officer to transform a large organisation. Passionate about product innovations that shape new customer experiences.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)